Find Afloqualone manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 56287-74-2, Arofuto, 4(3h)-quinazolinone, 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-, Airomate, Hq-495, Co4u2c8orz
Molecular Formula
C16H14FN3O
Molecular Weight
283.30  g/mol
InChI Key
VDOSWXIDETXFET-UHFFFAOYSA-N
FDA UNII
CO4U2C8ORZ

Afloqualone
1 2D Structure

Afloqualone

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4-one
2.1.2 InChI
InChI=1S/C16H14FN3O/c1-10-4-2-3-5-14(10)20-15(9-17)19-13-7-6-11(18)8-12(13)16(20)21/h2-8H,9,18H2,1H3
2.1.3 InChI Key
VDOSWXIDETXFET-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC=CC=C1N2C(=NC3=C(C2=O)C=C(C=C3)N)CF
2.2 Other Identifiers
2.2.1 UNII
CO4U2C8ORZ
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 56287-74-2

2. Arofuto

3. 4(3h)-quinazolinone, 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-

4. Airomate

5. Hq-495

6. Co4u2c8orz

7. 6-amino-2-(fluoromethyl)-3-(o-tolyl)quinazolin-4(3h)-one

8. 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4-one

9. 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-4(3h)-quinazolinone

10. 6-amino-2-(fluoromethyl)-3-o-tolyl-4(3h)-quinazolinone

11. Afloqualon

12. 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-quinazolin-4-one

13. 6-amino-2-(fluoromethyl)-3-o-tolylquinazolin-4(3h)-one

14. Afloqualona

15. Afloqualonum

16. Afloqualone [inn:jan]

17. Afloqualonum [inn-latin]

18. Afloqualona [inn-spanish]

19. Unii-co4u2c8orz

20. Hq 495

21. Brn 0819769

22. Airomate (tn)

23. 6-amino-2-(fluoromethyl)-3-o-tolyl-4(3h)-chinazolinon

24. Afloqualone [mi]

25. 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4(3h)-one

26. Afloqualone [inn]

27. Afloqualone [jan]

28. 6-amino-3,4-dihydro-2-fluoromethyl-3-(2-methylphenyl)-4-chinazolinon

29. Dsstox_cid_2562

30. Afloqualone (jp17/inn)

31. Afloqualone [mart.]

32. Dsstox_rid_76631

33. Dsstox_gsid_22562

34. Afloqualone [who-dd]

35. Mls006010086

36. Schembl400184

37. Chembl2105918

38. Dtxsid5022562

39. Chebi:31177

40. 6-amino-2-(fluoromethyl)-3-(2-methylphenyl)-4-quinazolinone

41. Hms3885g19

42. Bcp13264

43. Hy-b1833

44. Tox21_112447

45. Mfcd00867693

46. S3663

47. Zinc13831145

48. Akos015842375

49. Ac-1608

50. Ccg-267278

51. Cs-5009

52. Ncgc00167443-02

53. As-11726

54. Smr004701231

55. Cas-56287-74-2

56. Ft-0653844

57. D01638

58. D95096

59. A830986

60. Q4689289

61. 2-fluoromethyl-3-(o-tolyl)-6-amino-4(3h)-quinazolinone

62. 6-azanyl-2-(fluoranylmethyl)-3-(2-methylphenyl)quinazolin-4-one

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 283.30 g/mol
Molecular Formula C16H14FN3O
XLogP32.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass283.11209024 g/mol
Monoisotopic Mass283.11209024 g/mol
Topological Polar Surface Area58.7 Ų
Heavy Atom Count21
Formal Charge0
Complexity439
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Muscle Relaxants, Central

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)


Photosensitizing Agents

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)


4.2 Metabolism/Metabolites

Afloqualone has known human metabolites that include Afloqualone N-glucuronide.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty